PRIMARY DRUG RESISTANCE TO ANTHRACYCLINE ANTIBIOTICS IN PATIENTS WITH LOCALLY DISSEMINATED BREAST CANCER POSSIBILITY ITS OVERCOMING

The frequency of primarily resistant to anthracycline antibiotics tumors is assessed in locally disseminated breast cancer patients. Findings are presented dealing with the successful use of liposomal doxorubicin in neoadjuvant polychemotherapy regimens with the view of overcoming primary drug resistance.



No comments » Add comment